The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sacituzumab govitecan in patients with advanced or metastatic radioactive-iodine refractory thyroid carcinoma: The phase 2 SETHY, GETNE-T2318 trial.
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Gilead Sciences (Inst); Ipsen (Inst); Ipsen (Inst); ITM Solucin (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Eisai; Gilead Sciences; Ipsen; Pfizer
 
Beatriz Castelo Fernández
No Relationships to Disclose
 
Carlos López
No Relationships to Disclose
 
Javier Martínez-Trufero
Consulting or Advisory Role - Boehringer Ingelheim Spain; Deciphera; Eisai; GlaxoSmithKline; PharmaMar
Research Funding - Ayala Pharmaceuticals (Inst); BionTech (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Kariopharm Therapeutics (Inst); Lilly (Inst); PharmaMar (Inst); Syneos Health (Inst); SynOX (Inst)
Travel, Accommodations, Expenses - Merck; PharmaMar; PharmaMar; Roche
 
Teresa Alonso-Gordoa
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Eisai; Ipsen; Janssen-Cilag; Lilly; MSD Oncology; Pfizer
Research Funding - Ipsen; Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Alberto Carmona-Bayonas
No Relationships to Disclose
 
Gloria Marquina
Honoraria - AstraZeneca; AstraZeneca Spain; Eisai; Eisai; Eisai; Eisai; Eisai; GlaxoSmithKline; Grunenthal; Grunenthal; Ipsen; Lilly; MSD; MSD Oncology; PharmaMar; Roche; Roche; Tesaro
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Eisai; GlaxoSmithKline; PharmaMar; PharmaMar; Tesaro
Travel, Accommodations, Expenses - Angelini Pharma; Clovis Oncology; Eisai; Eisai; Lilly; Lilly; Lilly; Merck; MSD; MSD; Pfizer; Pfizer; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Tesaro; Tesaro
Other Relationship - GlaxoSmithKline; Tesaro; Tesaro
 
Nieves Martinez Lago
No Relationships to Disclose
 
Paula Jimenez-Fonseca
Speakers' Bureau - BMS GmbH & Co. KG; Lilly
Other Relationship - IPSEN
 
María Plana Serrahima
Honoraria - BMS
Travel, Accommodations, Expenses - MSD Oncology
 
Enrique Grande
Honoraria - Abbott/AbbVie; Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; AVEO; Bristol-Myers Squibb; Dr. Reddy's Laboratories; Eisai; Eusa Pharma; EUSA Pharma; GlaxoSmithKline; IPSEN; Janssen-Cilag; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; AVEO; Bristol-Myers Squibb; Gilead Sciences; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ipsen (Inst); Lexicon (Inst); Merck KGaA (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche/Genentech
 
Jorge Hernando
Speakers' Bureau - Advanced Accelerator Applications; Angelini Pharma; Bayer; Eisai; Ipsen; Novartis; Roche
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Eisai; Ipsen; Novartis; Roche
 
Alejandro Garcia-Alvarez
Speakers' Bureau - Angelini Pharma; Eisai; Eisai Europe
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Advanz Pharma; Advanz Pharma; Amgen; Eisai Europe; Ipsen; Pfizer